GB1041279A - 13-alkyl steroid ketones - Google Patents

13-alkyl steroid ketones

Info

Publication number
GB1041279A
GB1041279A GB37618/61A GB3761861A GB1041279A GB 1041279 A GB1041279 A GB 1041279A GB 37618/61 A GB37618/61 A GB 37618/61A GB 3761861 A GB3761861 A GB 3761861A GB 1041279 A GB1041279 A GB 1041279A
Authority
GB
United Kingdom
Prior art keywords
group
steroid
formula
ethylenic bond
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB37618/61A
Other languages
English (en)
Inventor
Gordon Alan Hughes
Herchel Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB37617/61A priority Critical patent/GB1041278A/en
Priority to GB37618/61A priority patent/GB1041279A/en
Priority to SE01423/67A priority patent/SE335526B/xx
Priority to SE11026/62A priority patent/SE313809B/xx
Priority to SE11024/62A priority patent/SE312552B/xx
Priority to SE11025/62A priority patent/SE312553B/xx
Priority to SE11023/62A priority patent/SE312551B/xx
Priority to CH1275267A priority patent/CH459195A/de
Priority to CH1217162A priority patent/CH450407A/de
Priority to CH1562566A priority patent/CH455763A/de
Priority to DK448162AA priority patent/DK113641B/da
Priority to CH1562766A priority patent/CH432509A/de
Priority to CH1562666A priority patent/CH450408A/de
Priority to NO146142A priority patent/NO122645B/no
Priority to NO146140A priority patent/NO122643B/no
Priority to DE19621793595 priority patent/DE1793595C3/de
Priority to DE1962S0111837 priority patent/DE1617818B2/de
Priority to FI1879/62A priority patent/FI41027B/fi
Priority to FI1876/62A priority patent/FI41024B/fi
Priority to NO146141A priority patent/NO122644B/no
Priority to DK449762AA priority patent/DK115621B/da
Priority to DK449562AA priority patent/DK121228B/da
Priority to ES281669A priority patent/ES281669A1/es
Priority to DE1962S0082099 priority patent/DE1468604C2/de
Priority to FI1877/62A priority patent/FI41025B/fi
Priority to DE19621793608 priority patent/DE1793608B1/de
Priority to NO146143A priority patent/NO122646B/no
Priority to FI1878/62A priority patent/FI41026B/fi
Priority to DE19621618855 priority patent/DE1618855B2/de
Priority to AT822762A priority patent/AT264730B/de
Priority to DK449662AA priority patent/DK115549B/da
Priority to AT825762A priority patent/AT256355B/de
Priority to AT825862A priority patent/AT256356B/de
Priority to AT825662A priority patent/AT256354B/de
Priority to FR921556A priority patent/FR2796M/fr
Priority to SE05984/66A priority patent/SE340619B/xx
Publication of GB1041279A publication Critical patent/GB1041279A/en
Priority to CY42968A priority patent/CY429A/xx
Priority to MY196875A priority patent/MY6800075A/xx
Priority to DK227069AA priority patent/DK129652B/da
Priority to DK339670AA priority patent/DK124753B/da
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00—Footwear characterised by the shape or the use
    • A43B3/12—Sandals; Strap guides thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Woven Fabrics (AREA)
GB37618/61A 1961-10-19 1961-10-19 13-alkyl steroid ketones Expired GB1041279A (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GB37617/61A GB1041278A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketone derivatives
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones
SE01423/67A SE335526B (de) 1961-10-19 1962-10-15
SE11026/62A SE313809B (de) 1961-10-19 1962-10-15
SE11024/62A SE312552B (de) 1961-10-19 1962-10-15
SE11025/62A SE312553B (de) 1961-10-19 1962-10-15
SE11023/62A SE312551B (de) 1961-10-19 1962-10-15
CH1275267A CH459195A (de) 1961-10-19 1962-10-17 Verfahren zur Herstellung von 13-Alkyl-steroid-diolen
CH1217162A CH450407A (de) 1961-10-19 1962-10-17 Verfahren zur Herstellung von 13-homologisierten Steroid-Ketonen
CH1562566A CH455763A (de) 1961-10-19 1962-10-17 Verfahren zur Herstellung von Steroid-Ketonen
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
CH1562766A CH432509A (de) 1961-10-19 1962-10-17 Verfahren zur Herstellung von Steroid-Ketonen
CH1562666A CH450408A (de) 1961-10-19 1962-10-17 Verfahren zur Herstellung von Steroid-Ketonen
NO146141A NO122644B (de) 1961-10-19 1962-10-18
DE19621618855 DE1618855B2 (de) 1961-10-19 1962-10-18 Gonanen-3,17-diole und verfahren zu ihrer herstellung
DE19621793595 DE1793595C3 (de) 1961-10-19 1962-10-18 Zwischenprodukte zur Herstellung von 17 alpha-Alkyl-, -Alkenyl- oder -Alkinyl-13 beta-alkylgon-4- oder -5(10)-en-17 beta-ol-3-onen
DE1962S0111837 DE1617818B2 (de) 1961-10-19 1962-10-18 Oral verabreichbare oder injizierbare antikonzeptionsmittel
FI1879/62A FI41027B (de) 1961-10-19 1962-10-18
FI1876/62A FI41024B (de) 1961-10-19 1962-10-18
NO146142A NO122645B (de) 1961-10-19 1962-10-18
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
ES281669A ES281669A1 (es) 1961-10-19 1962-10-18 Un procedimiento para preparar una cetona esteroide
DE1962S0082099 DE1468604C2 (de) 1961-10-19 1962-10-18 Verfahren zur Herstellung von 17alpha-Alkyl-,-Alkenyl- oder -Alkinyl-13beta-alkylgon-4-oder-5(10)-en-17beta-ol-3-onen
FI1877/62A FI41025B (de) 1961-10-19 1962-10-18
DE19621793608 DE1793608B1 (de) 1961-10-19 1962-10-18 17alpha-Alkyl-,-Alkenyl- oder -Alkinyl-13ss-alkylgon-4-oder-5(10)-en-17ss-ol-3-one
NO146143A NO122646B (de) 1961-10-19 1962-10-18
FI1878/62A FI41026B (de) 1961-10-19 1962-10-18
NO146140A NO122643B (de) 1961-10-19 1962-10-18
AT822762A AT264730B (de) 1961-10-19 1962-10-18 Verfahren zur Herstellung von neuen Steroidketonen
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
AT825762A AT256355B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen
AT825862A AT256356B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen 17-Alkyl-steroidketonen
AT825662A AT256354B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten Steroidketonen
FR921556A FR2796M (fr) 1961-10-19 1963-01-16 Médicaments nouveaux constitués par des cétostéroides apparentés a la 19-nortestostérone.
SE05984/66A SE340619B (de) 1961-10-19 1966-05-02
CY42968A CY429A (en) 1961-10-19 1968-01-15 13-Alkyl steroid ketones
MY196875A MY6800075A (en) 1961-10-19 1968-12-31 13-alkyl steroid ketones
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones

Publications (1)

Publication Number Publication Date
GB1041279A true GB1041279A (en) 1966-09-01

Family

ID=10397775

Family Applications (2)

Application Number Title Priority Date Filing Date
GB37618/61A Expired GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones
GB37617/61A Expired GB1041278A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketone derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB37617/61A Expired GB1041278A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketone derivatives

Country Status (12)

Country Link
AT (4) AT264730B (de)
CH (5) CH450407A (de)
CY (1) CY429A (de)
DE (4) DE1617818B2 (de)
DK (6) DK113641B (de)
ES (1) ES281669A1 (de)
FI (4) FI41024B (de)
FR (1) FR2796M (de)
GB (2) GB1041279A (de)
MY (1) MY6800075A (de)
NO (4) NO122646B (de)
SE (6) SE312552B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617751B2 (en) 2006-07-06 2023-04-04 Bayer Pharma AG Pharmaceutical composition containing a tetrahydrofolic acid

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617751B2 (en) 2006-07-06 2023-04-04 Bayer Pharma AG Pharmaceutical composition containing a tetrahydrofolic acid

Also Published As

Publication number Publication date
DE1617818A1 (de) 1972-05-18
SE312552B (de) 1969-07-21
NO122643B (de) 1971-07-26
FI41027B (de) 1969-04-30
DE1468604B1 (de) 1970-07-02
DK115549B (da) 1969-10-20
FI41026B (de) 1969-04-30
CH450407A (de) 1968-01-31
DE1793595B2 (de) 1975-10-30
MY6800075A (en) 1968-12-31
SE313809B (de) 1969-08-25
DE1618855C3 (de) 1973-10-25
SE312553B (de) 1969-07-21
AT256355B (de) 1967-08-25
DE1468604C2 (de) 1971-03-04
SE340619B (de) 1971-11-29
NO122646B (de) 1971-07-26
DK124753B (da) 1972-11-20
DK121228B (da) 1971-09-27
AT256354B (de) 1967-08-25
AT256356B (de) 1967-08-25
DE1618855A1 (de) 1972-05-18
ES281669A1 (es) 1963-03-16
FR2796M (fr) 1964-09-21
DE1793595A1 (de) 1972-02-03
NO122644B (de) 1971-07-26
CH432509A (de) 1967-03-31
DK129652C (de) 1975-04-07
CH455763A (de) 1968-05-15
DK129652B (da) 1974-11-04
GB1041278A (en) 1966-09-01
FI41025B (de) 1969-04-30
DE1793608B1 (de) 1972-05-04
DE1618855B2 (de) 1973-04-05
AT264730B (de) 1968-09-10
CH450408A (de) 1968-01-31
CH459195A (de) 1968-07-15
FI41024B (de) 1969-04-30
DK113641B (da) 1969-04-14
DE1617818B2 (de) 1976-12-09
SE312551B (de) 1969-07-21
SE335526B (de) 1971-06-01
CY429A (en) 1968-01-15
NO122645B (de) 1971-07-26
DK115621B (da) 1969-10-27

Similar Documents

Publication Publication Date Title
GB1152226A (en) Novel Gona-1,3,5(10)-Trienes, processes for their preparation, and compositions incorporating them
GB1041279A (en) 13-alkyl steroid ketones
US3134771A (en) 3-tetrahydropyranyl ethers of estra-1,3,5(10)-trienes
Nutting et al. Anabolic-androgenic activity of A-ring modified androstane derivatives. Part I: A comparison of parenteral activity
GB1010052A (en) 13-alkyl steroids related to oestradiol
GB928805A (en) Steroid compounds
GB950899A (en) Improvements in or relating to steroidal alkyl ethers
GB1010051A (en) 13-alkyl steroids related to oestrone
GB1068500A (en) Improvements in or relating to b-norestrogens
Fahmy et al. Metabolism of 19-hydroxy-C19-steroids by human corpus luteum
GB927165A (en) Improvements in or relating to steroids
GB991933A (en) Tetracyclic aromatic diene compounds
GB1041277A (en) 13-alkyl steroids related to oestradiol
GB911428A (en) Steroids
GB1185381A (en) 05,16beta-Methylene Steroids of the 19-Nor-Androstane Series and Process for their Manufacture
GB999738A (en) Therapeutic compositions containing estrones
ES274471A1 (es) Un procedimiento para preparar 4-hidroxi-3-ceto-delta-esteroides
GB985482A (en) 2-methylene testosterone derivatives and methods for producing the same
GB1103204A (en) 6,13 and 7,13-dialkylgonatetraene compounds
GB934574A (en) Steroids
GB1010054A (en) 13-alkyl steroids related to 19-nortestosterone
GB1006788A (en) Improvements in or relating to the preparation of steroids
GB911740A (en) Enolethers of 2- or 6-substituted í~-3-ketones of the androstane series
GB1248225A (en) 05beta,16beta-METHYLENE-STEROIDS
GB1094390A (en) Preparation of í¸-pregnatriene compounds